That's brilliant. AYMK I've thought for many years we are in the
information business not the chemistry business, so why not have a
charging structure that reflects that?
Obviously if a result is looked at many times it's more valuable.
Presumably a test with higher power is also more valuable.
But don't I remember a seminal* study that showed quite a lot of
reports were never looked at? That could seriously hurt your income
stream with this approach!
Jonathan
* Just in case this is too subtle for new group members:
http://bmj.bmjjournals.com/cgi/content/full/322/7294/1101
On 11 Feb 2004, at 14:50, Eric Kilpatrick wrote:
>
> A few months ago, as a possible way round this, we considered
> charging the test costs to both recipients of any 'copy to' reports!
>
> Eric
------ACB discussion List Information--------
This is an open discussion list for the academic and clinical
community working in clinical biochemistry.
Please note, archived messages are public and can be viewed
via the internet. Views expressed are those of the individual and
they are responsible for all message content.
ACB Web Site
http://www.acb.org.uk
List Archives
http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html
List Instructions (How to leave etc.)
http://www.jiscmail.ac.uk/
|